Bristol-Myers Squibb Company (BMY) News Today: Latest Market and Industry Updates
59.12
0.4500
0.76 %
At close
10/09
USD
Daily range
58.88
59.79
59.79
Weekly range
58.36
60.08
60.08
Bristol-Myers Squibb stock approaches $57.39 support: Key levels to watch
Bristol-Myers Squibb (BMY) stock is trading at $59.07, down 3.41% today. The price is positioned below its key moving averages, reflecting ongoing downside ...
AstraZeneca acquisition talks with Bristol Myers Squibb collapse amid investor backlash
AstraZeneca ends discussions over a potential tie-up with Bristol Myers Squibb after market resistance builds around what could have been one of the biggest pharmaceutical deals on record. The ...
AstraZeneca explores Bristol Myers Squibb merger as investors weigh growth and patent risks
A potential combination between AstraZeneca and Bristol Myers Squibb is drawing scrutiny over whether scale in oncology and cardiovascular drugs can justify the strategic trade-offs. The proposed ...
U.S. stock futures rise as Middle East hopes ease oil, healthcare deal talk lifts Bristol Myers
U.S. stock index futures are moving higher on Monday as easing tensions in the Middle East push crude prices lower and steady investors after a weak July for Wall Street. Markets are also turning ...
FTSE 100 slips as AstraZeneca merger talks weigh on healthcare stocks
London equities trade mixed on Monday as weakness in heavyweight healthcare and energy names offsets gains in rate-sensitive stocks. AstraZeneca leads blue-chip decliners after reports of ...
AstraZeneca explores Bristol Myers Squibb merger to create nearly $400bn drug group
Consolidation pressure in global pharmaceuticals is driving AstraZeneca to examine a combination with Bristol Myers Squibb that would rank among the largest healthcare mergers ever attempted. The ...
UK launches dementia registry to support trials and life sciences investment
The UK is launching a nationwide virtual registry for people living with dementia as it seeks to accelerate treatment development and improve access to clinical trials. The platform, backed by the ...
Elliott Management alumni launch new activist hedge funds as the firm’s Wall Street reach expands
Activist investing continues to broaden around Paul Singer’s Elliott Management as former staff build their own funds and carry its tactics into new campaigns. The expansion comes as Elliott ...
What triggered Bristol-Myers Squibb shares' latest price surge
Bristol-Myers Squibb Company (BMY) surged 3.7% after the company reaffirmed its pipeline priorities and protections around U.S. patents, drawing renewed institutional focus to its flagship ...
Bristol-Myers Squibb stock edges higher as Immunai collaboration advances its oncology platform
Bristol-Myers Squibb (BMY) stock is trading at $55.76, gaining 1.37% on the day. The price sits above its key moving averages, reflecting underlying positive ...
